Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Mar 23 2021
Published Mar 23 2021
5 min read

Press Release Mar 23 2021

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 23, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Diltiazem Hydrochloride Extended‐Release Capsules USP, 60 mg, 90 mg, and 120 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity".

View Attachment